Japan Psoriasis Drug Market Size & Outlook, 2025-2033

Japan Psoriasis Drug Market Insights

As highlighted in Reed Intelligence analysis, the Japan Psoriasis Drug Market, worth USD 294.98 Million in 2024, is forecasted to achieve USD 775.18 Million by 2033.
The Japan market is anticipated to grow at a CAGR of 11.41% during the period 2026–2033.
By 2024, Biologics represented the largest share of the By Drug Class market size.
Others is expected to remain the key growth driver within By Drug Class, registering the fastest CAGR during the forecast period.

Other Key Findings

As of 2024, Japan held 2.39% of the global Psoriasis Drug Market size.
By 2033, United States is anticipated to capture the largest share of the global Psoriasis Drug Market.
In Asia Pacific, China is expected to lead the regional Psoriasis Drug Market size by 2033.
Japan will remain the fastest-growing market in Asia Pacific, reaching USD 780.03 Million by 2033.

Report Summary

Report Scope	Details
Base Year for Study	2024
Study Period	2021-2033
Historical Period	2021-2023
Forecast Period	2025-2033
Market Size In 2024	USD 294.98 Million
Market Size In 2033	USD 775.18 Million
Largest segment	Biologics
Units	Revenue in USD Million
CAGR	11.41% (2025-2033)
Segmnetation Covered
By Drug Class	Biologics Corticosteroids Vitamin D Analogs Others
By Therapeutic Class	Tumour Necrosis Factor (TNF) Phosphodiesterase Type 4 (PDE4) Interleukin Others
By Route of Administration	Oral Parenteral Topical
By Distribution Chanel	Hospital Pharmacies Retail Pharmacies E-commerce Others
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Japan Psoriasis Drug Market By Drug Class 2025-2033 (USD Million)

By Drug Class	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Biologics	XX.x	XX.x	XX.x	127.61	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Corticosteroids	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Vitamin D Analogs	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Others	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Japan Psoriasis Drug Market By Therapeutic Class 2025-2033 (USD Million)

By Therapeutic Class	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Tumour Necrosis Factor (TNF)	XX.x	XX.x	XX.x	123.77	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Phosphodiesterase Type 4 (PDE4)	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Interleukin	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Others	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Japan Psoriasis Drug Market By Route of Administration 2025-2033 (USD Million)

By Route of Administration	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Oral	XX.x	XX.x	XX.x	141.24	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Parenteral	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Topical	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Japan Psoriasis Drug Market By Distribution Chanel 2025-2033 (USD Million)

By Distribution Chanel	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Hospital Pharmacies	XX.x	XX.x	XX.x	144.39	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Retail Pharmacies	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
E-commerce	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Others	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Author :

Reed Intelligence Research Team

The Reed Intelligence Research Team brings together over 15+ years of collective experience in market research, data analytics, and strategic consulting. Comprising seasoned analysts, economists, and industry specialists, the team delivers precise, data-driven insights across sectors including technology, healthcare, energy, manufacturing, and consumer goods. By combining domain expertise with modern analytical tools, they ensure each report meets the highest standards of accuracy and relevance.